Development and validation of a high-performance liquid chromatographic method for the determination of methocarbamol in human plasma

Multi-template molecularly imprinted polymer hybrid nanoparticles for selective analysis of nonsteroidal anti-inflammatory drugs and analgesics in biological and pharmaceutical samples

The multi-template molecularly imprinted polymers reinforced with hybrid oxide nanoparticles were developed for the selective separation and determination of the trace level of naproxen (NPX), methocarbamol (MTH), and omeprazole (OMZ) simultaneously from biological and pharmaceutical samples. The polymers were constructed by magnetic core@shell molecularly imprinted polymer nanocomposite (Fe₃O₄/ZnO/CuO/MWCNT@MIP). An electrochemical sensor has been fabricated for this purpose. Fe₃O₄/ZnO/CuO/MWCNT nanocomposite was introduced to improve the electron transport capability and increase the sensor surface area, as well as enhance the electronic conductivity. The triple-template MIP-coated layer provides simultaneous selective identification of three analytes by using [Fe (CN)₆]^3-/4-as the redox probe. Electrochemical behavior of MTH, NPX, and OMZ on the modified electrode (Fe₃O₄/ZnO/CuO/MWCNT@MIP) by various techniques such as cyclic voltammetry, differential pulse voltammetry, and chronoamperometry was examined. The morphology of the modified and unmodified carbon paste electrodes was performed by scanning electron microscopy (SEM) and X-ray diffraction analysis (XRD). The average crystal size for fabricated nanoparticles obtained by calculating the X-ray diffraction technique was 17 nm in the Scherer method. The particle size which was determined by SEM was 48 nm. Some electrochemical parameters such as the diffusion coefficient and electron transfer coefficient were determined. The effect of many variables such as the pH and scan rate was also investigated. Under optimal conditions, the sensor is designed in the linear range 5.0 nM-100 μM and 5.0 nM-100 μM and 1.0 nM-130 μM with a detection limit of 1.5 nM, 1.0 nM, and 0.7 nM for measurement OMZ, NPX, and MTH, respectively. The relative standard deviation (RSD) of the five measurements was 1.21%, 2.23%, and 2.56% for NPX, MTH, and OMZ. Finally, the designed sensor was successfully used for simultaneous detection of target analytes in the real samples; tablets, water samples, and biological samples.

Gamma irradiation-induced degradation and mineralization of methocarbamol in aqueous solution

Gamma irradiation degradation of the extensively used muscle relaxant in the world methocarbamol (MET) was studied. MET aqueous solutions were irradiated by gamma rays emitted by a Cobalt 60 source at doses of 1-4 kGy. Our findings demonstrated that gamma irradiation degraded more than 98.5% of MET. Absorption spectra analysis revealed that when increased irradiation dose, the absorption bands declined with complete disappearance at 4 kGy dose. Additionally, the most radiolytic degradation rate was recorded at neutral pH, marked by Total Organic Carbon (TOC) removal rate of 98% reflecting the total mineralization of MET at 4 kGy. In-depth spectrophotometric analyses advocated a pseudo-first-order type of MET degradation kinetics. The obtained apparent rate constant value was k_{app, MET} = (0.02167 ± 0.0006) min^-1. Gas chromatography-mass spectrometry (GC-MS) allowed the detection of 3-(o-methoxyphenoxy)-1,2 propanediol,2-methoxyphenol, 1,2,3 propanetriol, 1,2-dihydroxybenzene and 1,2,4 benzentriol identified as by-products generated during radiolytic degradation. Finally, an outline of the degradation mechanism was suggested according to the obtained by-products.

The pharmacokinetics of methocarbamol and guaifenesin after single intravenous and multiple-dose oral administration of methocarbamol in the horse

A simple LC/MSMS method has been developed and fully validated to determine concentrations and characterize the concentration vs. time course of methocarbamol (MCBL) and guaifenesin (GGE) in plasma after a single intravenous dose and multiple oral dose administrations of MCBL to conditioned Thoroughbred horses. The plasma concentration-time profiles for MCBL after a single intravenous dose of 15 mg/kg of MCBL were best described by a three-compartment model. Mean extrapolated peak (C0 ) plasma concentrations were 23.2 (± 5.93) μg/mL. Terminal half-life, volume of distribution at steady-state, mean residence time, and systemic clearance were characterized by a median (range) of 2.96 (2.46-4.71) h, 1.05 (0.943-1.21) L/kg, 1.98 (1.45-2.51) h, and 8.99 (6.68-10.8) mL/min/kg, respectively. Oral dose of MCBL was characterized by a median (range) terminal half-life, mean transit time, mean absorption time, and apparent oral clearance of 2.89 (2.21-4.88) h, 2.67 (1.80-2.87) h, 0.410 (0.350-0.770) h, and 16.5 (13.0-20) mL/min/kg. Bioavailability of orally administered MCBL was characterized by a median (range) of 54.4 (43.2-72.8)%. Guaifenesin plasma concentrations were below the limit of detection in all samples collected after the single intravenous dose of MCBL whereas they were detected for up to 24 h after the last dose of the multiple-dose oral regimen. This difference may be attributed to first-pass metabolism of MCBL to GGE after oral administration and may provide a means of differentiating the two routes of administration.

Rationally designed molecularly imprinted polymers for selective extraction of methocarbamol from human plasma

Molecularly imprinted polymers (MIPs) with high selectivity toward methocarbamol have been computationally designed and synthesized based on the general non-covalent molecular imprinting approach. A virtual library consisting of 18 functional monomers was built and possible interactions between the template and functional monomers were investigated using a semiempirical approach. The monomers with the highest binding scores were then considered for additional calculations using a more accurate quantum mechanical (QM) calculation exploiting the density functional theory (DFT) at B3LYP/6-31G(d,p) level. The cosmo polarizable continuum model (CPCM) was also used to simulate the polymerization solvent. On the basis of computational results, acrylic acid (AA) and tetrahydrofuran (THF) were found to be the best choices of functional monomer and polymerization solvent, respectively. MIPs were then synthesized by the precipitation polymerization method and used as selective adsorbents to develop a molecularly imprinted solid-phase extraction (MISPE) procedure before quantitative analysis. After MISPE the drug could be determined either by differential pulse voltammetry (DPV), on a glassy carbon electrode modified with multiwalled-carbon nanotubes (GC/MWNT), or high performance chromatography (HPLC) with UV detection. A comparative study between MISPE-DPV and MISPE-HPLC-UV was performed. The MISPE-DPV was more sensitive but both techniques showed similar accuracy and precision.

Determination of methocarbamol concentration in human plasma by high performance liquid chromatography-tandem mass spectrometry

A simple and reproducible high performance liquid chromatography-tandem mass spectrometric method was developed for methocarbamol analysis in human plasma. Methocarbamol and the internal standard (IS) were extracted by a protein precipitation method. Under isocratic separation condition the chromatographic run time was 3.0 min. The calibration curve was linear over a range of 150-12,000 ng/mL with good intraday assay and interday assay precision (CV%<10.9%). The method was proven to be sensitive and selective for the analysis of methocarbamol in human plasma for bioequivalence study.